Skip to content

Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.

D Jeremy Stewart, Hesham Fahmy, Bryan L. Roth, Feng Yan, Jordan K Zjawiony

Arzneimittel-Forschung 2006 DOI: 10.1055/s-0031-1296720 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Intervention Salvinorin A
Topics Salvia divinorum
Key points Salvinorin A bioisosteres were synthesized and tested for opioid receptor binding and function. The C-2 thioacetate isostere had activity comparable to salvinorin A, nitrogen substitution diminished activity, and intermediates without a C-2 beta-carbonyl had moderate affinity. All derivatives were selective for the kappa-opioid receptor over other opioid subtypes.

Abstract

Salvinorin A ((2S,4aR,6aR,7R,9S,10aS, 10bR)-2H-naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo methyl ester, 1, CAS 83729-01-5) has been shown to bind with high affinity and selectivity to the kappa-opioid receptor (KOR) as an agonist. Bioisosteres of 1 were developed and biologically evaluated in binding and functional assays. The C-2 thioacetate isoster produced comparable activity to 1, but nitrogen substitution had a diminishing effect. Intermediates, which lack a beta-carbonyl at C-2, displayed moderate affinity. The derivatives were tested against all opioid subtypes and were selective towards KOR.

Citations in the library

Explore topics